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Abstract: Immobilized microfluidic enzyme reactors (IMER) are of particular interest for automation of
enzyme cascade reactions. Within an IMER, substrates are converted by paralleled immobilized enzyme
modules and intermediate products are transported for further conversion by subsequent enzyme modules. By
optimizing substrate conversion in the spatially separated enzyme modules purification of intermediate
products is not necessary, thus shortening process time and increasing space-time yields. The IMER enables
the development of efficient enzyme cascades by combining compatible enzymatic reactions in different
arrangements under optimal conditions and the possibility of a cost-benefit analysis prior to scale-up. These
features are of special interest for automation of enzymatic glycan synthesis. We here demonstrate a
compartmented flow microreactor system using six magnetic enzyme beads (MEBs) for the synthesis of the
non-sulfated human natural killer cell-1 (HNK-1) glycan epitope. MEBs are assembled to build compartmented
enzyme modules, consisting of enzyme cascades for the synthesis of uridine 5’- diphospho-α- d-galactose
(UDP-Gal) and uridine 5’-diphospho-α-d-glucuronic acid (UDP-GlcA), the donor substrates for the Leloir
glycosyltransferases β4-galactosyltransferase and β3-glucuronosyltransferase, respectively. Glycan synthesis
was realized in an automated microreactor system by a cascade of individual enzyme module compartments
each performing under optimal conditions. The products were analyzed inline by an MS-system connected to
the microreactor. The high synthesis yield of 96% for the non-sulfated HNK-1 glycan epitope indicates the
excellent performance of the automated enzyme module cascade. Furthermore, combinations of other MEBs
for nucleotide sugars synthesis with MEBs of glycosyltransferases have the potential for a fully automated and
programmed glycan synthesis in a compartmented flow microreactor system.
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Introduction
Carbohydrate molecules linked to other compounds
such as proteins and lipids are called glycoconjugates
and serve various functions, including cell-to-cell and
cell-to-matrix communication as well as cross-linking
between proteins.[1] For chemical stereoselective and
regioselective glycosylations, multi-step syntheses are
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necessary because the numerous hydroxyl groups
present on individual sugars must be selectively
protected and deprotected.[2] This is even more severe
in case of an automated chemical glycan synthesis, as
each step must be optimized for high product yields.
Moreover, lengthy and time-consuming procedures are
also required for the removal of by-products, such as
stereoisomers, regioisomers, unreacted intermediates.
Elegant strategies have been developed to address
these challenges for automated chemical glycan syn-
thesis leading up to hexasaccharides and even a 50mer
of a homopolysaccharide.[3] However, yields are still
low or moderate. In contrast, enzyme-assisted glycan
synthesis is an attractive alternative to chemical syn-
thesis as it has the advantage of achieving regio- and
stereoselective glycosylations in a single step.
Although strict enzyme substrate specificity appears as
a disadvantage, a whole enzyme toolbox for glycosyla-
tion reactions and synthesis of nucleotide sugars as
precursors of glycosyltransferases is now available for
enzymatic synthesis of complex glycans.[4] Automated
enzymatic synthesis is, therefore, an emerging and still
developing technology. With glycosyltransferases in
solution, automated glycan using solid-phase, polymer-
bound[5] or tagged substrates for capture and release of
products[6] have been developed, each strategy with its
own pros and cons as discussed in recent reviews.[7] A
common disadvantage is that glycosyltransferase reac-
tions are not optimized for high product yields in short
reaction time, and the precious biocatalysts are not
recovered and reused. Relevant numbers for space-
time-yield (STY, g product L  1 day  1) and product-
specific total turnover number TTN (g product/g
catalyst) are therefore low for automated enzymatic
synthesis. Only a few immobilized Leloir-type glyco-
syltransferases have been applied in glycan synthesis.[8]
Key to high enzyme activity is the oriented immobili-
zation on surfaces or polymers mediated by terminal
peptides or proteins. Leloir-type glycosyltransferases
and enzymes for nucleotide sugar synthesis have been
immobilized via their polyhistidine tags.[9] Immobilized
His-tagged enzymes can show activities close to those
in solution due to the highly specific orientation
provided by the His6 linkage.
[10] Magnetic particles are
well suited as carriers because of their easy separation
by magnetic fields, thus resulting in an enzyme-free
product without time-consuming and expensive purifi-
cation steps.
In addition, magnetic carriers simplify the imple-
mentation of automated processes and protocols, thus
allowing the automation of complex multistep enzy-
matic cascades. A sophisticated example is demon-
strated in this work by handling enzymes immobilized
on magnetic particles in an automated compartmented
flow microreactor system (CFMS). The principle of
the CFMS was described before[11] illustrating the
system well suitable for automated optimization of
bioprocesses applying single immobilized enzymes, in
this case, immobilized β1,4-galactosyltransferase. The
reaction progress can be monitored online with
spectroscopic methods and the temperature can be
controlled precisely.
The herein used enzyme modules (EM) have been
optimized and combined in our previous studies
employing soluble enzymes (Scheme 1A). Galactoki-
nase (GalK) was combined with UDP-sugar pyrophos-
phorylase (USP) in an enzyme cascade reaction for the
synthesis of UDP-galactose (UDP-Gal, 3) from d-
(+)-galactose (Gal,1) via α-d-galactose-1-phosphate
(Gal-1-P, 2) in the EM-UDP-Gal.[12] In the EM-UDP-
GlcA, UDP-glucose-dehydrogenase (UGDH) generates
Uridine 5’-diphosphate-glucuronic acid (UDP-GlcA, 5)
from UDP-glucose (UDP-Glc, 4), while NADH
oxidase (NOX) regenerates the co-substrate NAD+.[13]
In the EM-GalT, β1,4-galactosyltransferase (GalT)
transfers galactose from UDP-Gal onto a tert-butylox-
ycarbonyl protected N-acetylglucosamine (GlcNAc-
linker-tBoc, 6) to synthesize N-Acetyl-d-lactosamine
(LacNAc-linker-tBoc, 7).[14] The UDP-GlcA, produced
in the EM-UDP-GlcA, was used for glucuronosyltrans-
ferase (GlcAT) to transfer the GlcA onto LacNAc-
linker-tBoc in the EM-GlcAT, resulting in the product
non-sulfated human natural killer cell-1 (HNK-1)
epitope (8).[15]
In this work, we demonstrate automated enzymatic
glycan synthesis by enzyme cascade reactions, con-
ducted in the CFMS, using six different enzymes
immobilized on magnetic particles (Scheme 1A). Nu-
cleotide sugars are synthesized in parallel enzyme
modules (EM) and subsequently delivered to the
reaction of two glycosyltransferases to synthesize the
final product 8 with a yield of 96% (Scheme 1B).
Product formation of individual glycosyltransferase
steps was confirmed by an inline MS-system. To the
best of our knowledge, such a high number of
magnetic enzyme beads (MEB) has not yet been
employed for biocatalytic cascades before; it is the first
example for automated glycan synthesis in a compart-
mented microfluidic microreactor.
Results and Discussion
Enzyme Loading Yields of the Immobilization Step
Table 1 displays an overview of the loading yields of
the PureCube Ni  IDA particles for all tested enzyme
amounts, expressed as theoretical loadings in g
immobilized enzyme per L settled beads. For UGDH
the loading yields varied between 58% and 67% and
for NOX between 56% and 80%. The loading yields of
GalK, GalT, and GlcAT were around the same range of
73%–93%. Immobilizing USP led to loading yields of
nearly 100%. Analyzing correlations between loading
yield and theoretical loading, UGDH, USP, and GlcAT
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show a decreasing trend of the yield with increasing
theoretical loading, the yield at 50 g/L being an
exception. No correlation of loading yield and theoret-
ical loading was found for immobilized NOX, GalK
and GalT, if the 50 g/L tests are excluded. An increase
of the loading yield with increasing theoretical loading
would be unusual since the number of free binding
sites decreases and more steric hindrance occur. For
the reaction cascade in the CFMS, the 50 g/L MEB
were used.
Scheme 1. Enzyme cascade using magnetic enzyme beads (MEB). A: Enzyme modules (dotted line) with magnetic enzyme beads
(MEB) for the synthesis of the donor substrates UDP-Gal (3) and UDP-GlcA (5) were combined for glycosylation reactions by the
glycosyltransferases β4GalT to yield LacNAc (7) and β3GlcAT for the synthesis of HNK-1 epitope (8). B: Flowchart of the reaction
cascade in the compartmented flow microreactor system (CFMS). Box: reaction compartment with magnetic enzyme beads (MEB);
circle: product compartment for transport to the next reaction compartment. Each compartment has a volume of 150 μL; EM
reactions were carried out at 37 °C.
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Determination of the Optimum Reaction Parame-
ters of the Magnetic Enzyme Beads MEB
To find the parameters giving the highest specific
activity U/mg immobilized enzyme, for each immobi-
lized enzyme, the effects of the reaction parameters
were analyzed in a partially automated procedure in
the CFMS in a ‘one-factor-at-a-time’ approach. The
resulting optimal parameters of our immobilized
enzymes and the optimal parameters of the respective
free enzymes from literature are listed in Table 2. As
can be seen, the values of the optimal reaction
parameters for the immobilized enzymes largely
correspond with those reported in the literature.[13,15–17]
The highest specific activity of immobilized
UGDH, NOX, and GalK was achieved with the lowest
loadings (see Figure S1, supporting information). By
increasing the enzyme load, the specific activity
decreased. This effect often occurs with immobilized
enzymes and is explained by the fact that immobilized
enzymes that are in close proximity to each other
influence each other by steric hindrance. This impairs
the binding of the substrates with the active sites and
thus the activity.[19] In contrast, immobilized USP,
GalT, and GlcAT displayed an increase of specific
activity by rising enzyme loading. In this case, steric
hindrance seems not to occur, which could be
explained by a superior arrangement of these immobi-
lized enzymes. The optimal values for pH and temper-
ature did not differ much from published data.
The occurrence of the maximum specific activity at
higher temperatures indicates a stabilization of the
MEB against heat denaturation. In comparison with the
literature, the Km value differed from around 2.5 times
smaller to nearly 15 times higher and the vmax value
from about 8 times smaller to more than two times
higher (see Figure S2–S4, supporting information).
Table 1. Loading yields of all immobilized enzymes inves-
tigated. The first column shows the theoretical loading in g
immobilized enzyme per L settled beads. The enzyme concen-
tration used for immobilization was 0.15 g enzyme per L
reaction solution in all cases.
Theoretical
enzyme
loading (g/L)
Loading yields of His6-tagged enzymes [%]
UGDH NOX GalK USP GalT GlcAT
2.5 64 56 74 99 n.d. n.d.
5 67 67 93 95 78 85
10 58 63 83 94 73 78
15 n.d[a] n.d n.d n.d 76 73
30 56 70 n.d n.d n.d. n.d.
50 64 80 87 94 84 86
[a] not determined.
Table 2. Experimentally determined optimal reaction conditions and kinetic data, compared to data from the literature in brackets.
UGDH NOX GalK USP β4GalT β3GlcAT
pH-optimum 9.5 (9.7) 6 (6–6.5) 7.5 (7.5) 7.5 (7.5) 7.5 (7.5) 6.5 (6.5)
Temperature-
optimum
40 °C
(30 °C) 25 °C(30–40 °C) 40 °C(40 °C) 45 °C(45 °C) 40 °C(30 °C) 50 °C(45 °C)
Loading
(theoretical)
2.5 g/L 2.5 g/L 5 g/L 50 g/L 50 g/L 15 g/L
vmax UDP-Glc:
0.12 U/mg
(0.81 U/mg)
NADH+H+:
16.8 U/mg
(116 U/mg)
Gal:
1.9 U/mg
(5 U/mg)
Gal-1-P:
10.6 U/mg
(13.1 U/mg)
GlcNAc-linker-
tBoc:
0.68 U/mg
(1.13 U/mg)
LacNAc-linker-
tBoc:
1.1 U/mg
(0.48 U/mg)
NAD+:
0.11 U/mg
(0.92 U/mg)
ATP:
1.13 U/mg
(6.5 U/mg)
UTP:
11.7 U/mg
UDP-Gal:
1.1 U/mg
UDP-GlcA:
1.2 U/mg
(0.45 U/mg)
Km UDP-Glc:
0.09 mM
(0.03 mM)
NADH+H+:
0.37 mM
(0.024 mM)
Gal:
1.54 mM
(0.24 mM)
Gal-1-P:
1.1 mM
(0.83 mM)
GlcNAc-linker-
tBoc:
0.72 mM
(3.07 mM)
LacNAc-linker-
tBoc:
0.99 mM
(0.24 mM)
NAD+:
0.16 mM
(0.44 mM)
ATP:
0.7 mM
(0.31 mM)
UTP:
1.6 mM
UDP-Gal:
5.4 mM
UDP-GlcA:
0.59 mM
(0.19 mM)
Ki – – Gal:
1.8 mM
(33.1 mM)
UTP:
1.87 mM
GlcNAc-linker-
tBoc:
3.24 mM
(2.66 mM)
–
ATP:
3.15 mM
(5.8 mM)
Reference [13,15] [16,18] [13] [12] [14,17] [15]
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The GalK, USP and GalT MEB displayed a substrate
inhibition as stated in the literature for the free
enzymes.[12,13,17] Immobilization via complex binding
can cause a change in Km values, for example, if the
binding of the active site is impaired by the Ni  IDA
functionalization of the magnetic particles. Also, if the
immobilization causes the orientation of the catalytic
center which is not optimal for the substrate to bind,
the Km value can change. In summary, the usefulness
of the CFMS for semi-automated parameter screening
and optimization of enzymatic reactions could be
demonstrated with a multitude of different immobi-
lized enzymes and tested parameters.
Recycling of the MEB
The results of the recycling of immobilized UGDH are
shown as the percentage residual activity in Fig-
ure 1A). After the second cycle, 81% residual activity
could be measured. Subsequently, it gradually de-
creased by 9% to 16%. During the fourth cycle, the
residual activity of 55% was measured and in the
seventh cycle about 35%. Wahl et al. achieved a
residual activity of 50% after 3 h reaction time with
free UGDH.[13] This corresponds to about six cycles,
where the immobilized UGDH showed about 37% of
the original specific activity. In the case of MEB
loaded with NOX, the specific activity decreased by
nearly 85% after the first recycling. Published data of
free NOX already shows the low stability of NOX,
with a half-life time of 10 min and 10–20% residual
activity after 30 min.[13] The results of the repeated
assays with immobilized GalK show a fairly constant
decrease of the residual activity until the fifth cycle. At
the last cycle, the residual activity of around 50%
remains about the same. For the immobilized USP, the
graph (see Figure 1B) shows a similar course, with a
slightly higher residual activity of around 55% after
six assays. The specific activity of immobilized
β4GalT decreased by almost 40% after the first assay
but reached an approximately constant residual activity
of around 50% during the further cycles up to seven
repetitions. Finally, the course of the residual activity
of immobilized β3GlcAT did not change significantly
for the first three cycles. Subsequently, the residual
activity decreased to 61% at the sixth cycle with an
outlier in the fifth cycle. In summary, with the
exception of NOX, all other MEB showed a residual
activity of around 40–60% after six or seven cycles.
This offers the possibility for multiple reuses of the
MEB also in complex enzymatic cascades, where the
MEB could be easily recovered and replaced individu-
ally, while the use of free enzymes would lead to a
mixture after the first run of the cascade with limited
use for further runs.
Automated Enzymatic Glycan Synthesis
With optimal reaction conditions for MEB, the syn-
thesis of the non-sulfated HNK-1 epitope in the reactor
system was investigated. Different mixing ratios of
MEB and substrate concentrations were investigated
(see Figure S5A/B, supporting information). With
2 mM of the starting substrates 1 and 4, EM-UDP-
GlcA and EM-UDP-Gal reached conversions of 97.7%
and 99.2%, respectively. The EM-GalT performed with
99.7% conversion of the available substrate 6. Finally,
after additional 60 min, the EM-GlcAT converted 98%
substrate 7 from EM-GalT and 99.3% substrate 5 from
EM-UDP-GlcA, resulting in a total yield of 96.3% for
8 with respect to initial substrate concentrations (Fig-
ure 2A). The respective HPLC analysis is displayed in
Figure S6 in the supporting information.
Product formation in the MEB CFMS system
(Scheme 1B) was analyzed by ESI-Q-ToF MS. The
mass spectrum of the reaction solution before adding
Figure 1. Reuse of immobilized (A) UGDH, NOX, GalK and (B) USP, GalT, GlcAT in multiple cycles.
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β4GalT (Figure 3A) shows the substrate GlcNAc-link-
er-tBoc 6 with a molecular mass (m/z) of 422. The
molecular mass m/z 444 Da derives from the sodium
adduct replacing a proton by a sodium of the buffer
solution. Transfer of galactose (180 Da) by β4GalT
onto 6 results in a water molecule and the 162 Da
bigger LacNAc-linker-tBoc 7 (Figure 3B). In the EM-
GlcAT, the 194 Da GlcA from previously produced
UDP-GlcA is transferred resulting in the 760 Da non-
sulfated HNK-1 epitope 8 (Figure 3C).
For comparison, the same reaction sequence was
performed with soluble enzymes with the same
reaction solution composition (see Table 3). In contrast
to the application of MEB, the soluble enzymes could
not be separated from the reaction solution after use
and remained in the solution during the following steps
of the cascade. After 210 min, a total yield of 57.5%
for 8 was achieved (Figure S5C, supporting informa-
tion). The EM-UDP-Gal had the lowest yield of
75.5%, the EM UDP GlcA the highest of 100%. In the
EM-UDP-Gal GalK had initially converted almost
91% of 1 and USP 83% of 2, which led to the total
yield of 75.5% for UDP-Gal 3. The free β4GalT also
converted almost 83% of 3.
In comparison, the use of immobilized enzymes in
the reactor system could synthesize almost 40% more
non-sulfated HNK-1 epitope. The advantage of com-
partmentation is that optimal reaction conditions for a
defined enzyme module are applied. In addition, the
time- and cost-intensive removal of soluble enzymes
from intermediate and final product volumes is not
necessary with the MEB.
Theoretical Simulation of Automated Enzymatic
Glycan Synthesis
In addition to the experimental work, the reaction
cascade with MEB was also simulated based on the
kinetic data obtained with single MEB systems (see
Figure 2B). The simulated EM-UDP-GlcA and EM-
UDP-Gal both achieved a conversion of 100%, where-
by in the experiment the EM-UDP-GlcA had 97.7%
Figure 2. Yields of the optimized reaction cascade with MEB in the reactor system as (A) experimental, (B) simulated data. Applied
enzyme modules: (I) EM-UDP-GlcA, (II) EM- UDP-Gal, (III) EM-GalT and (VI) EM-GlcAT. Intermediates and products: (-*-)
UDP-GlcA (5), (-&-) UDP-Gal (3), (-!-) LacNAc-linker-tBoc (7) and (-~-) non-sulfated HNK-1 epitope (8). For the substrates,
2 mM of UDP-Glc, Gal, ATP, UTP, GlcNAc-linker-tBoc, 4 mM NAD+, 8 mM MgCl2 and 6 mM MnCl2 were used (see Table 3).
The initial concentrations of the immobilized enzymes were 1 μg/μL for UGDH and NOX and 0.5 μg/μL for GalK, USP, GalT and
GlcAT.
Table 3. Composition of the reaction mixtures utilized in the optimized reactor cascade experiments in the CFMS and in the
approach with soluble enzymes. The volume of the EM-UDP-GlcA, EM-UDP-Gal and the reaction solution for the soluble enzymes
was 150 μL respectively. All experiments were conducted at 37 °C.
Experiments
(all numbers in mM)
Tris
pH 8.7
Tris/KCl pH 7.5 UDP-Glc NAD+ Gal ATP UTP MgCl2 MnCl2 GlcNAc-
linker-tBoc
Reaction cascade
in CFMS
EM-UDP-GlcA 100 – 2 4 – – – – –
EM-UDP-Gal/
EM-GalT
– 100/
25
– – 2 2 2 8 6 2
Approach with enzymes in
solution
– 100/
25
2 4 2 2 2 8 6 2
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Figure 3.MALDI-TOF mass spectra of the substrates and products of each step of the cascade reaction of immobilized GalT and
GlcAT. In A: the substrate GlcNAc-linker-tBoc (6) is marked, calculated mass (m/z): 422.2, in (B) the intermediate LacNAc-linker-
tBoc (7): calculated mass (m/z): 584.2; (C) the product non-sulfated HNK-1 epitope (8): calculated mass (m/z): 760.3. All samples
were diluted 1:10000.
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and EM-UDP-Gal 99.2% conversion. Based on these
substrate amounts, EM-GalT was simulated to convert
99.2%. In the experiment, EM-GalT surpassed the
simulation and converted 99.7% of 6. Further, simu-
lated EM-GlcAT converted 100% of the accessible
substrate, which led to a total yield of 99.2%. The
experimental EM-GlcAT converted 98% of 7 and
99.3% of 5, resulting in the total yield of 96.3% for 8.
The total turnover number (TTN) of the experiment
is therefore 0.37 gproduct* g  1 of all immobilized
enzymes and for the simulation 0.38 gproduct*g  1.
Thus, the simulation almost matches the experiment.
Based on the experiment in the CMFS and the results
of the recycling experiments, the reactor system would
be able to produce in total 40 mg non-sulfated HNK-1
epitope in 18 h, which would be 6 cycles. It was
assumed that a 3 mL compartment with 5 mM of
substrates would be used and that six cycles with the
same enzymes would be run. This would result in a
space-time yield (STY) of HNK-1 epitope of
17.63 g*L  1 *day  1. Considering the simulation, it can
be possible to reach a STY of 18.16 g*L  1 *day  1.
Conclusion
We here demonstrate for the first time glycan synthesis
in an automated compartmented flow microreactor by
a reaction cascade of six different magnetic enzyme
beads. Compared to other published enzyme cascades
in microreactors utilizing enzymes immobilized on
magnetic beads,[20] the number of applied enzymes and
the degree of automation is clearly increased, indicat-
ing the flexibility of the applied immobilization
method and of the developed compartmented reactor
device. Despite the high number of reaction steps, a
yield of 96% non-sulfated HNK-1 epitope could be
achieved. Thus, compared to an approach with soluble
enzymes, the yield was almost 40% higher. This again
demonstrates the great advantage of compartmentaliza-
tion in the microreactor system, which can provide
optimal reaction conditions for each reaction step and
prevent inhibition. The microreactor system can prod-
uct-specific to an MS-system for inline reaction control
and product analysis. Due to the modularity and
multiplexing of the microreactor system, the productiv-
ity could be increased by adding more tubes for
parallel reactions or even more complex cascades
consisting of more enzymes could be utilized. With
further immobilized enzyme modules in hand, auto-
mated synthesis of more complex glycans can be
realized in a compartmented flow microreactor.
Experimental Section
Magnetic Microcarriers
PureCube Ni  IDA MagBeads were purchased from Cube
Biotech GmbH (Monheim am Rhein, Germany) and used as
enzyme carriers without further modification. The ferrimagnetic
magnetite beads are coated with 6% cross-linked agarose,
functionalized with Ni  IDA and have a diameter of 25–30 μm.
According to the manufacturer, the beads have a binding
capacity of up to 70 mg (IDA) His-tagged protein/mL of settled
beads.
Enzymes and Chemicals
The enzymes studied in this work are fusion constructs with an
N-terminal polyhistidine (His6)-tag. The enzyme production
was done as described in our previous studies by Engels et al.[15]
for UDP-glucose-dehydrogenase (UGDH, EC 1.1.1.22), NADH
oxidase (NOX, EC 1.6.99.-) and β1,3glucuronyltransferase
(β3GlcAT, EC 2.4.1.17, and by Wahl et al.[13] for galactokinase
(GalK, EC 2.7.1.6) and for UDP-sugar pyrophosphorylase
(USP, EC 2.7.7.64),[12] and by Fischöder et al.[14] for β1,4-
galactosyltransferase (β4GalT, EC 2.4.1.38). The linker-modi-
fied substrate N-acetylglucosamine with a tert-butyloxycarbonyl
protected amino group (GlcNAc-linker-tBoc) was kindly
provided by Prof. Vladimír Křen (Institute of Microbiology,
Czech Academy of Sciences).[21] The inhibitory by-products PPi
and UDP were removed by inorganic pyrophosphatase (PPiase)
and alkaline phosphatase (FastAP), respectively, purchased
from Thermo Fisher Scientific (Rockford, USA). Standard
compounds comprising Uridine 5’-diphosphate-α-d-glucose
(UDP-Glc), nicotinamide adenine dinucleotide (NAD+), nicoti-
namide adenine dinucleotide hydride (NADH), d-(+)-Galactose
(Gal), adenosine 5’-triphosphate ATP, uridine 5’-triphosphate
(UTP), α-d-Galactose-1-phosphate (G-1-P), Uridine 5’-diphos-
phate-α-d-galactose (UDP-Gal) and Uridine 5’-diphosphate-α-
d-glucuronic acid (UDP-GlcA) were purchased from Sigma
Aldrich (Deisenhofen, Germany) or VWR International GmbH
(Bruchsal, Germany). All chemicals were analytical grade and
used without further purification. The water used for all
experiments was deionized and purified using a Milli-Q Ultra-
pure system from Merck Millipore KGaA (Darmstadt, Ger-
many).
Immobilization of the Enzymes
Purified His6-tagged enzymes were immobilized onto the
IDA  Ni functionalized surfaces of the magnetic particles. For
the immobilization, 5 μL particle slurry were used to bind 12.5/
25/50/75/150/250 μg of the enzymes resulting in a theoretical
loading of 2.5/5/10/15/30/50 g enzyme per L particle slurry.
The immobilization reaction was performed at room temper-
ature for 30 min in 1.5 mL Eppendorf tubes (Wesseling-
Berzdorf, Germany) and done in duplicates, using 250 μL
binding buffer. The binding buffer consisted of 20 mM Na2PO4/
200 mM NaCl at pH 6.8. After the immobilization step, the
samples were washed with (0.5 mL) 1 M NaCl buffer and twice
with storage/binding buffer 1 (0.5 mL) 100 Tris/25 mM KCl
buffer pH 7.5 or storage/reaction buffer 2 (0.5 mL) 50 mM Tris
buffer pH 8.7 to desorb non-bound enzymes. The enzyme
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particles were diluted to 10 μL particle slurry per mL storage
buffer and stored at 4 °C. To calculate the amount of bound
enzyme, the protein content in the incubation- and washing-
supernatants was determined using the bicinchoninic acid
(BCA) Protein Assay Reagent Kit from Thermo Scientific
Pierce (Rockford, USA) according to manufacturer’s instruc-
tions.
Activity Assay of Immobilized Enzymes in the
CFMS
To characterize the activity of the MEB in the microreactor
system with regard to pH, temperature, and loading, MEB were
pumped into the reaction tubing of the system. The MEB were
separated from the storage buffer (as described before),[22]
resuspended in 100 μL of a preheated reaction buffer compart-
ment and pumped to the temperature control module (TCM).
Details of the IR-unit for preheating and the TCM are discussed
by Heinzler et al.,[11] describing the reactor system. Compound
composition for the activity assays of the analyzed enzymes are
listed in Table S1 (supporting information). For each assay,
15 μg of MEB with a loading of 15 mg immobilized enzyme
per mL settled beads were used in a 100 μL compartment. To
avoid possible effects of enzyme deactivation, fresh MEB of the
same batch were used in each assay, except for the assays on
particle recycling. To test different temperatures, the activity of
15 mg/mL MEB was investigated at the respective optimal pH
value of the free enzymes according to literature (UGDH/NOX/
GalK,[13] USP,[12] GalT,[14] GlcAT[15]). The influence of different
pH values was investigated at the respective optimal temper-
ature of the free enzymes. Assays with various enzyme loadings
were conducted at the optimal pH values and temperatures. For
the kinetic studies, 15 mg/mL MEB were used at the optimal
conditions with variable substrate concentrations. The kinetic
constants were obtained by fitting a Michaelis-Menten equa-
tion v=vmax*[S]/(Km+ [S]) or a Michaelis-Menten equation
including additional substrate inhibition v= vmax/(1+Km/[S]+
[S]/Ki) to the experimental data, using the software Sigma Plot
11 (Systat Software GmbH, Erkrath, Germany). If two
substrates were used, the substrate, which was not varied in
each case, was added in excess. Thus, limiting effects could be
avoided and the corresponding kinetic parameters could be
determined for each substrate. Assay conditions for kinetic
studies are listed in Table S2 (supporting information). To
determine the specific activity of the enzymes UGDH and
NOX, the concentrations of the coproduct NADH in the
samples were determined by measuring the absorption of the
samples at 340 nm. For GalK, USP, GalT and GlcAT 30 μL of a
sample of the sample were injected in an HPLC system (Agilent
1100 series, Waldbronn, Germany) and measured at 254 nm.
For analytics of GalK and USP, a normal phase column
(TSKgel Amide-80, Tosoh Bioscience, Germany, 5 μm, 2.0×
250 mm) was used and for analytics of GalT and GlcAT a
reversed-phase column (SunFire, Waters, USA, 5 μm, 4.6×
150 mm). The concentration of the substrates/cosubstrates and
the products/coproducts were calculated by the ratio of each
peak area compared to the sum of the two peak areas and the
corresponding calibration curve of standards. From the resultant
concentrations, the activity was calculated by the increase of
product over time. One enzyme unit correlates with one μmol
product per minute. The mass-specific activity U/mg was
calculated for one enzyme unit per mg immobilized enzyme.
Recycling of the MEB
To determine the recyclability of the different MEB, several
activity assays were carried out in succession in which the
MEB were reused. Between the reactions, the MEB were
separated and washed three times with 200 μL reaction buffer.
Thereafter, they were resuspended in a new reaction solution
and transported to the TCM for the next cycle. To have enough
volume for taking samples, a 300 μl compartment was used
with the same compound and MEB concentration as stated
before. The specific activity of the first assay of the respective
enzyme was set as 100% residual activity.
Reaction Cascade in the CFMS
The reaction cascade (see Scheme 1B) was conducted in two
separate tubes of the temperature control module (TCM) of the
CFMS (Scheme S1A and B, supporting information) at 37 °C in
150 μL compartments. A compartment is an aqueous reaction
solution, separated by ethyl acetate (EtOAc) and created by
alternately pumping EtOAc and reaction solution within a
tubing (see Scheme S1C, supporting information). The corre-
sponding components of the reaction solutions of the compart-
ments are listed in Table 3. The concentrations of the immobi-
lized enzymes were 1 μg/μL for UGDH and NOX and 0.5 μg/
μL for GalK, USP, GalT and GlcAT. Synthesis of UDP-GlcA
was conducted for 150 min parallel to a synthesis of LacNAc-
linker-tBoc. The reaction compartment EM-UDP-Gal contained
MEB and 1 μL of 0.1 U/μL PPiase to generate UDP-Gal within
90 minutes reaction time. After separation of MEB, the product
compartment was transported to the MEB of the EM-GalT. The
solution already contained the substrate GlcNAc-linker-tBoc
and 1 U/μL FastAP was added to hydrolyze the byproduct UDP.
GalT synthesized LacNAc-linker-tBoc within 60 minutes. In a
similar way, UDP-GlcA was produced in a parallel reaction
compartment within 150 min reaction time. After MEB separa-
tion, both product compartments were combined and added to
the MEB of the EM-GlcAT. The synthesis was conducted for
60 minutes. The product concentrations were determined by
HPLC.
For analytics of EM-UDP-GlcA, a reversed-phase column
(TSKgel ODS-100V, Tosoh Bioscience, Germany, 4.6×
150 mm) was used. The mobile phase consisting of 30% (v/v)
of 50 mM ammonium acetate (pH 4.5) in acetonitrile was used
for 30 min at a flow rate of 0.3 mL*min  1, increased after
10 min to 40% (v/v) in 5 min and after 5 min decreased in
2 min to 30% (v/v). At 260 nm, 30 μL of the sample were
analyzed. The EM-UDP-Gal was analyzed with the normal
phase column TSKgel Amide-80 using 20 mM tert-Butylamine
as mobile phase at a flow rate of 0.9 mL*min  1. In 35 min 10%
(v/v) methanol was added. A sample of 30 μL was analyzed at
260 nm. Analytics of the EM-GalT and EM-GlcAT were done
with the reversed-phase column SunFire with 24% (v/v)
acetonitrile dissolved in MilliQ water with 0.1% formic acid as
eluent at a flow rate of 0.3 mL*min  1. For 30 min, 30 μL of
sample mas measured at 254 nm.
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In addition to the experiment in the CFMS, the reaction cascade
was simulated with the application SimBiology (MathWorks,
USA). The same reaction periods as in the experiment (see
Scheme 1B) were used. The previously obtained kinetic data
(see Table 2) were used as parameters for the simulation. For
substrate concentrations, the same amounts were utilized as in
the experiment (see Table 3).
For comparison, an experiment was conducted with the same
amount of soluble enzymes in the same parallel reaction
sequence using the same composition of the reaction solutions
in the reactor system. The soluble enzymes were sequentially
added to the reaction solutions for each EM. GalT was added to
the reaction solution of EM-UDP-Gal after 90 min and
subsequently incubated for a further 60 min. In parallel, the
EM-UDP-GlcA was conducted for 150 min. The solutions of
both reactions were combined and GlcAT was added. The
reaction was stopped after 60 min, by adding 50 μL acetonitrile
(ACN).
Inline Connection Between the Reactor and a Mass
Spectrometer
To provide inline analytics, the reactor system was connected to
an ESI-Q-ToF MS-System (QSTAR Pulsar I, SCIEX, USA)
(see Scheme S2, supporting information). For this purpose, a
syringe pump, an additional high-pressure multiport valve
(Cetoni, Korbußen, Germany) and a mixing reservoir (1.5 mL
Eppendorf tube, Wesseling-Berzdorf, Germany) were added to
the reactor system. The syringe pump delivers samples to the
mixing reservoir via the multiport valve, where they are diluted
with Milli-Q water before being pumped into the MS system.
Samples of the reaction solutions after 90 min, before starting
the EM-GalT, after 150 min, before starting the EM-GlcAT, and
at the end of the reaction cascade after 210 min were measured
(Scheme 1B).
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